Refine
Year of publication
Language
- English (542)
Has Fulltext
- yes (542)
Is part of the Bibliography
- no (542)
Keywords
- Heavy Ion Experiments (9)
- LHC (9)
- Hadron-Hadron scattering (experiments) (6)
- ALICE experiment (4)
- ALICE (3)
- Hadron-Hadron Scattering (3)
- Heavy Ions (3)
- Heavy-ion collision (3)
- SARS-CoV-2 (3)
- pp collisions (3)
- Beauty production (2)
- COVID-19 (2)
- Charm physics (2)
- NASH (2)
- Pb–Pb collisions (2)
- Single electrons (2)
- antiviral therapy (2)
- 2-deoxy-d-glucose (1)
- 900 GeV (1)
- ACE inhibitor (1)
- ACLF (1)
- ALICE detector (1)
- AT1 receptor antagonist (1)
- Anti-nuclei (1)
- Breast cancer (1)
- CD47 (1)
- CVID (1)
- Cancer detection and diagnosis (1)
- Cell-to-Cell Spread (1)
- Cellular (1)
- Centrality Class (1)
- Centrality Selection (1)
- Comparison with QCD (1)
- Conservation biogeography (1)
- Cytoskeletal proteins (1)
- DNA mismatch repair (1)
- Electron-pion identification (1)
- Elliptic flow (1)
- European Society for Immunodeficiencies (ESID) (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Genetic causes of cancer (1)
- Genetic testing (1)
- Genetic wildlife monitoring (1)
- German PID-NET registry (1)
- HBT (1)
- Hadron production (1)
- Hair sampling (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion collisions (1)
- Histology (1)
- Human genetics (1)
- IAP (1)
- IgG substitution therapy (1)
- Inclusive spectra (1)
- Intensity interferometry (1)
- Invariant Mass Distribution (1)
- Ionisation energy loss (1)
- Jets (1)
- Lure sticks (1)
- MLH1 (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Monte Carlo (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- NAFLD (1)
- Neural network (1)
- Noninvasive genetic sampling (1)
- Nuclear modification factor (1)
- Oncology (1)
- Ovarian cancer (1)
- PID prevalence (1)
- PYTHIA (1)
- Particle correlations and fluctuations (1)
- Pb–Pb (1)
- Production Cross Section (1)
- Proton–proton (1)
- QCD (1)
- Quark gluon plasma (1)
- Rapidity Range (1)
- Relativistic heavy ion physics (1)
- Resolution Parameter (1)
- Roux-en-Y gastric bypass (1)
- SIRPalpha (1)
- SPTAN1 (1)
- SR-BI (1)
- SVR (1)
- Single muons (1)
- Systematic Uncertainty (1)
- TR (1)
- Time Projection Chamber (1)
- Tracking (1)
- Transition radiation detector (1)
- Transverse momentum (1)
- Trigger (1)
- Xenon-based gas mixture (1)
- bacterial translocation (1)
- benfooxythiamine (1)
- cell barrier integrity (1)
- coronavirus (1)
- dE/dx (1)
- fibrosis (1)
- heavy ion experiments (1)
- hepatic stellate cells (1)
- hepatocellular cancer (1)
- in vitro models (1)
- inflammation (1)
- mini gastric bypass (1)
- one anastomosis gastric bypass (1)
- oxLDL (1)
- oxythiamine (1)
- pentose phosphate pathway (1)
- primary immunodeficiency (PID) (1)
- quark gluon plasma (1)
- registry for primary immunodeficiency (1)
- spectra (1)
- steatosis (1)
- weight loss (1)
- √sN N = 2.76 TeV (1)
- fibrogenesis (1)
Institute
Pseudomonas aeruginosa is a human pathogen that causes health-care associated blood stream infections (BSI). Although P. aeruginosa BSI are associated with high mortality rates, the clinical relevance of pathogen-derived prognostic biomarker to identify patients at risk for unfavorable outcome remains largely unexplored. We found novel pathogen-derived prognostic biomarker candidates by applying a multi-omics approach on a multicenter sepsis patient cohort. Multi-level Cox regression was used to investigate the relation between patient characteristics and pathogen features (2298 accessory genes, 1078 core protein levels, 107 parsimony-informative variations in reported virulence factors) with 30-day mortality. Our analysis revealed that presence of the helP gene encoding a putative DEAD-box helicase was independently associated with a fatal outcome (hazard ratio 2.01, p = 0.05). helP is located within a region related to the pathogenicity island PAPI-1 in close proximity to a pil gene cluster, which has been associated with horizontal gene transfer. Besides helP, elevated protein levels of the bacterial flagellum protein FliL (hazard ratio 3.44, p < 0.001) and of a bacterioferritin-like protein (hazard ratio 1.74, p = 0.003) increased the risk of death, while high protein levels of a putative aminotransferase were associated with an improved outcome (hazard ratio 0.12, p < 0.001). The prognostic potential of biomarker candidates and clinical factors was confirmed with different machine learning approaches using training and hold-out datasets. The helP genotype appeared the most attractive biomarker for clinical risk stratification due to its relevant predictive power and ease of detection.
SARS-CoV-2 is causing the coronavirus disease 2019 (COVID-19) pandemic, for which effective pharmacological therapies are needed. SARS-CoV-2 induces a shift of the host cell metabolism towards glycolysis, and the glycolysis inhibitor 2-deoxy-d-glucose (2DG), which interferes with SARS-CoV-2 infection, is under development for the treatment of COVID-19 patients. The glycolytic pathway generates intermediates that supply the non-oxidative branch of the pentose phosphate pathway (PPP). In this study, the analysis of proteomics data indicated increased transketolase (TKT) levels in SARS-CoV-2-infected cells, suggesting that a role is played by the non-oxidative PPP. In agreement, the TKT inhibitor benfooxythiamine (BOT) inhibited SARS-CoV-2 replication and increased the anti-SARS-CoV-2 activity of 2DG. In conclusion, SARS-CoV-2 infection is associated with changes in the regulation of the PPP. The TKT inhibitor BOT inhibited SARS-CoV-2 replication and increased the activity of the glycolysis inhibitor 2DG. Notably, metabolic drugs like BOT and 2DG may also interfere with COVID-19-associated immunopathology by modifying the metabolism of immune cells in addition to inhibiting SARS-CoV-2 replication. Hence, they may improve COVID-19 therapy outcomes by exerting antiviral and immunomodulatory effects.